Get the Stockscreener App
86.85
0.07%
0.2395
Lemaitre Vascular Inc stock is traded at $86.85, with a volume of 52,607.
It is up +0.07% in the last 24 hours and down -1.34% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$86.61
Open:
$86.43
24h Volume:
52,607
Relative Volume:
0.31
Market Cap:
$1.97B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
47.46
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
-3.83%
1M Performance:
-1.34%
6M Performance:
+10.13%
1Y Performance:
-8.65%
1-Day Range:
$84.41
$87.20
1-Week Range:
$84.41
$90.51
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
86.81 | 1.96B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
541.74 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
176.67 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.50 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.66 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
278.75 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Will earnings trigger a reversal in LeMaitre Vascular Inc.Earnings Beat & Safe Swing Trade Setups - newser.com
Will LeMaitre Vascular Inc. (LHU) stock enhance shareholder valuePortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Will LeMaitre Vascular Inc. (LHU) stock beat Nasdaq index returns2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Is LeMaitre Vascular Inc. stock ready for a breakoutJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
Applying Elliott Wave Theory to LeMaitre Vascular Inc.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
What catalysts could drive LeMaitre Vascular Inc. stock higherJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
LeMaitre Vascular Inc. stock momentum explainedRate Hike & Fast Entry Momentum Trade Alerts - newser.com
Will LeMaitre Vascular Inc. stock remain a Wall Street favoriteWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Geneva Capital Management LLC Has $76.01 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
What technical patterns form on LeMaitre Vascular Inc. (LHU) stock chartsJuly 2025 Opening Moves & Capital Protection Trade Alerts - newser.com
Is LeMaitre Vascular Inc LHU a good long term investmentStock Buy Signals & Superior Growth Investment - earlytimes.in
Will LeMaitre Vascular Inc. stock attract more institutional investorsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
What hedge fund moves indicate for LeMaitre Vascular Inc. (LHU) stockMarket Trend Report & Growth-Oriented Investment Plans - newser.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How to read the order book for LeMaitre Vascular Inc.Market Volume Summary & Safe Swing Trade Setup Alerts - newser.com
LeMaitre Vascular, Inc. (LMAT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Press Releases about LeMaitre Vascular, Inc.Common Stock - FinancialContent
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Published on: 2025-10-30 01:49:16 - newser.com
LeMaitre Vascular (LMAT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will LeMaitre Vascular Inc. stock benefit from green energy trendsJuly 2025 Rallies & Daily Price Action Insights - newser.com
LeMaitre Vascular, Inc. (LMAT) Stock forecasts - Yahoo! Finance UK
Will LeMaitre Vascular Inc. (LHU) stock announce special dividendJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
How Investors May Respond To LeMaitre Vascular (LMAT) Raised Guidance and Insider Share Sales - Sahm
What drives LeMaitre Vascular Inc LHU stock priceCurrency Fluctuation Impact & Affordable Capital Growth - earlytimes.in
Can LeMaitre Vascular Inc. (LHU) stock withstand sector downturnsMarket Activity Report & Risk Controlled Daily Plans - fcp.pa.gov.br
Published on: 2025-10-28 03:55:12 - newser.com
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.73%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):